Will Uber Stock Recover?
Shares of Uber Technologies (NYSE:UBER) have had a rough few…
Sell
38
ENOV Quote, Financials, Valuation and Earnings
Last price:
$44.75
Seasonality move
:
2.44%
Day range:
$44.74 - $45.61
52-week range:
$38.27 - $65.03
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.23x
P/B ratio:
0.75x
Volume:
1.2M
Avg. volume:
636.4K
1-year change:
-23.38%
Market cap:
$2.5B
Revenue:
$1.7B
EPS (TTM):
-$2.19
Analysts' Opinion
-
Consensus RatingEnovis has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $66.00, Enovis has an estimated upside of 47.42% from its current price of $44.77.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $50.00 representing 100% downside risk from its current price of $44.77.
Fair Value
-
According to the consensus of 8 analysts, Enovis has 47.42% upside to fair value with a price target of $66.00 per share.
ENOV vs. S&P 500
-
Over the past 5 trading days, Enovis has overperformed the S&P 500 by 3.06% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Enovis does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Enovis has grown year-over-year revenues for 10 quarters straight. In the most recent quarter Enovis reported revenues of $505.2M.
Earnings Growth
-
Enovis has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Enovis reported earnings per share of -$0.58.
Enterprise value:
3.8B
EV / Invested capital:
--
Price / LTM sales:
1.23x
EV / EBIT:
--
EV / Revenue:
1.91x
PEG ratio (5yr expected):
-0.34x
EV / Free cash flow:
-61.65x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
21.46x
Gross Profit (TTM):
$1.1B
Return On Assets:
-2.35%
Net Income Margin (TTM):
-5.96%
Return On Equity:
-3.55%
Return On Invested Capital:
-2.75%
Operating Margin:
-5.28%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $1.6B | $1.7B | $2B | $417.5M | $505.2M | |
| Gross Profit | $845.6M | $958.1M | $1.1B | $243M | $286.5M | |
| Operating Income | -$82.1M | -$71.4M | -$88.6M | -$15.2M | -$26.7M | |
| EBITDA | $232.9M | $157M | $177.7M | $35.7M | $39.7M | |
| Diluted EPS | $0.43 | -$1.37 | -$2.19 | -$0.05 | -$0.58 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.3B | $1.7B | $1B | $854.2M | $1.2B | |
| Total Assets | $7.2B | $8B | $4.4B | $4.4B | $5.6B | |
| Current Liabilities | $784.5M | $975.5M | $853.9M | $355.3M | $530.2M | |
| Total Liabilities | $3.7B | $3.3B | $1B | $959.2M | $2.2B | |
| Total Equity | $3.5B | $4.6B | $3.4B | $3.4B | $3.3B | |
| Total Debt | $2.2B | $1.6B | $449.2M | $395M | $1.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $76.3M | $30.6M | $93.6M | $31M | $53.6M | |
| Cash From Investing | -$166.1M | -$220.2M | -$957M | -$17.1M | -$58.4M | |
| Cash From Financing | -$33.7M | $166.6M | $869.7M | -$13.7M | -$148K | |
| Free Cash Flow | -$23M | -$100.4M | -$61.9M | $4M | $2.4M | |
ENOV
Sector
Market Cap
$2.5B
$47.5M
Price % of 52-Week High
68.85%
47.37%
Dividend Yield
0%
0%
Shareholder Yield
-7.94%
-0.74%
1-Year Price Total Return
-23.38%
-34.04%
Beta (5-Year)
1.778
0.752
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$44.34
200-day SMA
Sell
Level
$46.92
Bollinger Bands (100)
Buy
Level
41.36 - 46.62
Chaikin Money Flow
Buy
Level
38.5M
20-day SMA
Buy
Level
$44.54
Relative Strength Index (RSI14)
Sell
Level
49.34
ADX Line
Buy
Level
21.3
Williams %R
Neutral
Level
-49.8574
50-day SMA
Sell
Level
$45.51
MACD (12, 26)
Sell
Level
-0.29
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
73.5M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.3383)
Buy
CA Score
(Annual)
Level (0.9324)
Buy
Beneish M-Score
(Annual)
Level (-2.7165)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-2.182)
Buy
Piotroski F Score
(Annual)
Level (7)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment.
Stock Forecast FAQ
In the current month, ENOV has received 7 Buy ratings 1 Hold ratings, and 0 Sell ratings. The ENOV average analyst price target in the past 3 months is $66.00.
-
Where Will Enovis Stock Be In 1 Year?
According to analysts, the consensus estimate is that Enovis share price will rise to $66.00 per share over the next 12 months.
-
What Do Analysts Say About Enovis?
Analysts are divided on their view about Enovis share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Enovis is a Sell and believe this share price will drop from its current level to $50.00.
-
What Is Enovis's Price Target?
The price target for Enovis over the next 1-year time period is forecast to be $66.00 according to 8 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is ENOV A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Enovis is a Buy. 7 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ENOV?
You can purchase shares of Enovis via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Enovis shares.
-
What Is The Enovis Share Price Today?
Enovis was last trading at $44.75 per share. This represents the most recent stock quote for Enovis. Yesterday, Enovis closed at $44.77 per share.
-
How To Buy Enovis Stock Online?
In order to purchase Enovis stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is ARK Next Generation Internet ETF a Good Investment?
The ARK Next Generation Internet ETF looks like a pretty…
Why Is Marvell Stock Up?
Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 39x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 114x
Sell
39
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
87
CEG alert for Jan 11
Constellation Energy [CEG] is up 25.15% over the past day.
Sell
1
MCY alert for Jan 11
Mercury General [MCY] is down 19.87% over the past day.
Buy
84
ATZAF alert for Jan 11
Aritzia [ATZAF] is up 17.63% over the past day.
